RECOMBINANT POLYPEPTIDES COMPRISING SINGLE-DOMAIN ANTIBODIES TARGETING HERV-K SUBTYPE HML-2
Technology
E-113-2022
Patent ID
E-113-2022-1-US-01
Country
US
Application Type
National Stage
Patent Status
Pending
Patent Number
Publication Number
Application Number
18/859,027
IC
NINDS
Date Filed
Date Issued
Patent PDF